BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals has submitted a routine compliance certificate to NSE for the October–December 2025 quarter. The certificate, issued by its Registrar and Share Transfer Agent (Aarthi Consultants Private Limited), confirms that all share certificates received from depository participants for dematerialization during the quarter were processed within the required 15-day timeline. The dematerialized securities continue to be listed on the stock exchanges where the company's shares are already listed. Old physical certificates were mutilated and cancelled, and the depository's name was updated as the registered owner in company records. This is a standard regulatory filing under SEBI's depositary rules.
This is a routine administrative filing with no material impact on the company's financials, operations, or shareholder value. It simply confirms that share dematerialization activities were carried out correctly during the quarter.